Therapeutic, Humanized Monoclonal Antibody Exhibits Broad Binding and Protective Efficacy against Acinetobacter baumannii

被引：5

作者：

Slarve, Matthew ^{[1
]}

Reyna, Zeferino ^{[1
]}

Burk, Elizabeth ^{[1
]}

Ruiz-Delgado, Juan ^{[1
]}

Li, Rachel ^{[1
]}

Yan, Jun ^{[1
]}

Luna, Brian ^{[1
]}

Spellberg, Brad ^{[2
]}

机构：

[1] Keck Sch Med USC, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA

[2] Angeles Cty USC LACUSC Med Ctr, Los Angeles, CA USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2023年 / 67卷 / 03期

关键词：

Acinetobacter baumannii; K antigen; monoclonal antibody; O antigen; antibiotic resistance; carbohydrates; therapeutic;

D O I：

10.1128/aac.00086-23

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Acinetobacter baumannii is an extremely drug-resistant pathogen necessitating the development of new therapies. We seek to generate a cocktail of monoclonal antibodies (MAbs) that can target the full diversity of A. baumannii isolates. We have newly identified the antibody MAb5. Here, we demonstrate that MAb5 has broad binding against U.S. (n = 300) and international (n = 250) isolates (72.24% and 28.76%, respectively), likely targets O-antigen capsular carbohydrates, and exhibits protective efficacy in vivo. Acinetobacter baumannii is an extremely drug-resistant pathogen necessitating the development of new therapies. We seek to generate a cocktail of monoclonal antibodies (MAbs) that can target the full diversity of A. baumannii isolates.

引用

页数：6

共 50 条

[31] Characterization of a Norovirus-specific monoclonal antibody that exhibits wide spectrum binding activities
Zheng, Lijun
Wang, Wenhui
Liu, Jinjin
Chen, Xuhui
Li, Sanjing
Wang, Qiaoli
Huo, Yuqi
Qin, Chuan
Shen, Shuo
Wang, Mingchen
JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (04) : 671 - 676
[32] Type I pili, CsuA/B and FimA induce a protective immune response against Acinetobacter baumannii
Ramezanalizadeh, Fatemeh
Owlia, Parviz
Rasooli, Iraj
VACCINE, 2020, 38 (34) : 5436 - 5446
[33] In vivo efficacy of phage cocktails against carbapenem resistance Acinetobacter baumannii in the rat pneumonia model
Li, Shibin
Wei, Bingdong
Xu, Le
Cong, Cong
Murtaza, Bilal
Wang, Lili
Li, Xiaoyu
Li, Jibin
Xu, Mu
Yin, Jiajun
Xu, Yongping
JOURNAL OF VIROLOGY, 2024, 98 (07)
[34] Lactobacilli-derived extracellular vesicles as synergistic biomolecules for colistin efficacy against Acinetobacter baumannii
Kim, Jisung
Cho, Hyejin
Kim, Kwang-sun
MICROBIOLOGICAL RESEARCH, 2025, 295
[35] The Efficacy of Imipenem Conjugated with Synthesized Silver Nanoparticles Against Acinetobacter baumannii Clinical Isolates, Iran
Zendegani, Elham
Dolatabadi, Samaneh
BIOLOGICAL TRACE ELEMENT RESEARCH, 2020, 197 (01) : 330 - 340
[36] Evaluation of sulbactam and colistin/sulbactam efficacy against multiple resistant Acinetobacter baumannii blood isolates
Heydarlou, Mehdi Meskini
Durmaz, Gul
Ibrahim, Bashar M. S.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2022, 40 (04) : 567 - 571
[37] In-Vitro Efficacy of Imipenem with Tigecycline and Amikacin against Extensively Drug Resistant Acinetobacter Baumannii
Zia, Afshan
Saleem, Sidrah
Imran, Muhammad
Arshad, Muhammad Usman
Ghazal, Ayesha
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (03): : 1098 - 1102
[38] Efficacy of the small molecule inhibitor of Lipid II BAS00127538 against Acinetobacter baumannii
de Leeuw, Erik P. H.
DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1061 - 1064
[39] In-Vitro Efficacy of Imipenem with Tigecycline and Amikacin against Extensively Drug Resistant Acinetobacter Baumannii
Zia, Afshan
Saleem, Sidrah
Imran, Muhammad
Arshad, Muhammad Usman
Ghazal, Ayesha
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2019, 13 (01): : 60 - 63
[40] Production and Identification of Broad Spectrum Monoclonal Antibody against a Group of Pyrethroid Insecticides
Wen Meng-Tang
Liu Yuan
Yan Shuai
Zhang Xiao
Wang Heng
Liu Xian-Jin
CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 2014, 42 (09) : 1245 - 1251

← 1 2 3 4 5 →